Aura Biosciences logo

Aura Biosciences Share Price (NASDAQ: AURA)

$6.26

-0.17

(-2.64%)

Last updated on

Check the interactive Aura Biosciences Stock chart to analyse performance

Aura Biosciences stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$6.23
    Today's High:$6.41

    Day's Volatility :2.81%

  • 52 Weeks Low:$4.35
    52 Weeks High:$12.38

    52 Weeks Volatility :64.9%

Aura Biosciences Stock Returns

PeriodAura Biosciences, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
1.62%
3.6%
0.0%
6 Months
-13.18%
-7.7%
0.0%
1 Year
-15.29%
-12.6%
0.0%
3 Years
-52.9%
9.5%
-4.7%

Aura Biosciences, Inc. Key Stats

Check Aura Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$6.43
Open
$6.41
Today's High
$6.41
Today's Low
$6.23
Market Capitalization
$399.4M
Today's Volume
$130.6K
52 Week High
$12.3782
52 Week Low
$4.345
Revenue TTM
$0.0
EBITDA
$-107.5M
Earnings Per Share (EPS)
$-1.95
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-55.39%

Stock Returns calculator for Aura Biosciences Stock including INR - Dollar returns

The Aura Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aura Biosciences investment value today

Current value as on today

₹84,026

Returns

₹15,974

(-15.97%)

Returns from Aura Biosciences Stock

₹21,258 (-21.26%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Aura Biosciences Stock

-19%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Aura Biosciences Stock from India on INDmoney has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Aura Biosciences, Inc.

  • Name

    Holdings %

  • Matrix Capital Management Company, LLC

    11.15%

  • Adage Capital Partners Gp LLC

    7.86%

  • Long Focus Capital Management, LLC

    7.44%

  • Suvretta Capital Management, LLC

    7.05%

  • BlackRock Inc

    5.70%

  • Medicxi Ventures Management (Jersey) Ltd

    4.90%

Analyst Recommendation on Aura Biosciences Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Aura Biosciences(by analysts ranked 0 to 5 stars)

Aura Biosciences Share Price Target

What analysts predicted

Upside of 235.46%

Target:

$21.00

Current:

$6.26

Aura Biosciences share price target is $21.00, a slight Upside of 235.46% compared to current price of $6.26 as per analysts' prediction.

Aura Biosciences Stock Insights

  • Price Movement

    In the last 7 days, AURA stock has moved down by -4.4%
  • AURA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 91.2%
  • AURA vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 165.4%

Aura Biosciences Technicals Summary

Sell

Neutral

Buy

Aura Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Aura Biosciences, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Aura Biosciences, Inc. logo
-7.12%
-13.18%
-15.29%
-52.9%
-57.7%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Aura Biosciences, Inc.

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer, as an alternative to bacillus calmette"guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Organization
Aura Biosciences
Employees
106
CEO
Dr. Elisabet de los Pinos Ph.D.
Industry
Healthcare

Key Management of Aura Biosciences, Inc.

NameTitle
Dr. Elisabet de los Pinos Ph.D.
Founder, CEO, President & Director
Mr. Conor Kilroy
Chief Legal Officer & Secretary
Dr. Jill J. Hopkins M.D.
Chief Medical Officer & President of Research and Development
Mr. Anthony S. Gibney
Chief Financial & Business Officer
Ms. Amy Elazzouzi
Interim Principal Accounting Officer, Senior VP of Finance & Treasurer
Dr. Mark Plavsic D.V.M., Ph.D.
Chief Technology Officer
Mr. Patrick Nealon
Senior Vice President of Clinical Development Operations
Dr. Anthony Daniels M.D.
VP & Therapeutic Area of Head Ocular Oncology
Dr. Richard Mountfield Ph.D.
Senior Vice President of Regulatory Affairs & Quality
Dr. Sabine Brookman-May
Senior VP & Therapeutic Area Head of Urologic Oncology

Important FAQs about investing in AURA Stock from India :

What is Aura Biosciences share price today?

Aura Biosciences share price today is $6.26 as on at the close of the market. Aura Biosciences share today touched a day high of $6.41 and a low of $6.23.

What is the 52 week high and 52 week low for Aura Biosciences share?

Aura Biosciences share touched a 52 week high of $12.38 and a 52 week low of $4.35. Aura Biosciences stock price today i.e. is closed at $6.26, lower by 49.43% versus the 52 week high.

How to invest in Aura Biosciences Stock (AURA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aura Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aura Biosciences Shares that will get you 0.2396 shares as per Aura Biosciences share price of $6.26 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Aura Biosciences Stock (AURA) from India?

Indian investors can start investing in Aura Biosciences (AURA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Aura Biosciences stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Aura Biosciences share’s latest price of $6.26 as on August 30, 2025 at 1:29 am IST, you will get 1.5974 shares of Aura Biosciences. Learn more about fractional shares .

What are the returns that Aura Biosciences has given to Indian investors in the last 5 years?

Aura Biosciences stock has given -57.7% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?